Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global malaria diagnostics industry is being driven by the growing prevalence of malaria among young children worldwide. In addition, the rapidly ageing population of the world is more susceptible to such diseases, which leads to increased morbidity and mortality rates. As a result, increased demand for quality diagnosis, treatment, and preventive solutions to combat malaria can be observed worldwide, especially in malaria-endemic regions. Moreover, governments are increasingly collaborating with international organisations to raise awareness regarding malaria and the preventive strategies among the masses while also ensuring the supply of required medications in the affected areas.
The rising emphasis of the leading players in the development of efficient diagnostic technology by applying advanced clinical solutions is expected to positively impact the industry growth in the forecast period. For instance, in January 2019, Abbott Laboratories (NYSE: ABT) announced its plans to support and partner with the state government of Odisha in India, and a non-profit organisation, Malaria no more, to provide technology, expertise, and financial support in their efforts to curb the spread of malaria in the region. Under this collaboration, Abbott is supplying 1 million rapid diagnostic tests (RDTs) and technical expertise to enhance Odisha's malaria detection and management system. Furthermore, another leading pharmaceutical manufacturer, GlaxoSmithKline (NYSE: GSK), in January 2021, announced that its single-dose Kozenis (tafenoquine) has been accepted by the Australian Therapeutic Goods Administration (TGA) for use among the paediatric populations as a radical cure that focuses on the prevention of relapse of Plasmodium vivax (P. vivax) malaria. Kozenis, a single dose treatment, was approved by the TGA for administration in 16 years and older and is supported by a Phase 2b clinical study (TEACH) that evaluated the dosage of the medicine tafenoquine based on the bodyweight of children at the age of 6 months. Such developments are expected to positively impact the growth of the malaria diagnostics industry in the forecast period.
Market Breakup by Technology and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global malaria diagnostics market are Access Bio Inc, Abbott Laboratories, Premier Medical Corporation Private Ltd., Sysmex Corporation, and bioMérieux SA, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.